INSERM U, Talence, France.
Angiogenesis. 2013 Jan;16(1):181-94. doi: 10.1007/s10456-012-9311-z. Epub 2012 Oct 18.
The clear cell subtype of renal carcinoma (CCRCC) is highly vascularized and despite a slow progression rate, it is potentially a highly aggressive tumor. Although a doubling of median progression-free survival in CCRCC patients treated by targeted therapies has been observed, the fact that tumors escape after anti-VEGF treatment suggests alternative pathways. The chick chorioallantoic membrane (CAM) is a well-established model, which allows in vivo studies of tumor angiogenesis and the testing of anti-angiogenic molecules. However, only a few data exist on CCRCC grafted onto CAM. We aimed to validate herein the CAM as a suitable model for studying the development of CCRCC and the interactions with the surrounding stroma. Our study uses both CCRCC cell lines and fresh tumor samples after surgical resection. We demonstrate that in both cases CCRCC can be grafted onto the CAM, to survive and to induce an angiogenic process. We further provide insights into the transcriptional regulation of the model by performing a differential analysis of tumor-derived and stroma-derived transcripts.
肾透明细胞癌(CCRCC)的透明细胞亚型具有高度血管生成性,尽管其进展速度较慢,但它是一种具有高度侵袭性的肿瘤。尽管靶向治疗可以使 CCRCC 患者的中位无进展生存期延长一倍,但肿瘤在抗 VEGF 治疗后逃逸的事实表明存在其他途径。鸡胚尿囊膜(CAM)是一种成熟的模型,可用于研究肿瘤血管生成和测试抗血管生成分子。然而,关于将 CCRCC 移植到 CAM 上的研究数据很少。我们旨在在此验证 CAM 作为研究 CCRCC 发展及其与周围基质相互作用的合适模型。我们的研究同时使用 CCRCC 细胞系和手术切除后的新鲜肿瘤样本。我们证明,在这两种情况下,CCRCC 都可以移植到 CAM 上并存活下来,从而诱导血管生成过程。我们通过对肿瘤来源和基质来源的转录本进行差异分析,进一步深入了解了该模型的转录调控。